Cargando…

A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial Cancers

The management of advanced or recurrent endometrial cancers presents a challenge due to the development of resistance to treatments. The knowledge regarding the role of the tumor microenvironment (TME) in determining the disease’s progression and treatment outcome has evolved in recent years. As a T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sulaiman, Raed, De, Pradip, Aske, Jennifer C., Lin, Xiaoqian, Dale, Adam, Gaster, Kris, Espaillat, Luis Rojas, Starks, David, Dey, Nandini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216115/ https://www.ncbi.nlm.nih.gov/pubmed/37238998 http://dx.doi.org/10.3390/biomedicines11051326

Ejemplares similares

Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to Drugs
por: Sulaiman, Raed, et al.
Publicado: (2023)

Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers
por: Sulaiman, Raed, et al.
Publicado: (2023)

Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial Cancers
por: Sulaiman, Raed, et al.
Publicado: (2022)

Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers
por: Sulaiman, Raed, et al.
Publicado: (2023)

Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance
por: De, Pradip, et al.
Publicado: (2022)

A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence
por: Sulaiman, Raed, et al.
Publicado: (2022)

Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime
por: Pradip, De, et al.
Publicado: (2021)

Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy
por: De, Pradip, et al.
Publicado: (2021)

Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR
por: Dey, Nandini, et al.
Publicado: (2021)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

RAC1 Takes the Lead in Solid Tumors
por: De, Pradip, et al.
Publicado: (2019)

Targeting Cell Cycle Progression in HER2+ Breast Cancer: An Emerging Treatment Opportunity
por: Koirala, Nischal, et al.
Publicado: (2022)

Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors
por: De, Pradip, et al.
Publicado: (2020)

Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
por: Geng, Xinglong, et al.
Publicado: (2021)

Vote for the GridCafé!
Publicado: (2004)

The Condor based CDF CAF
por: Würthwein, F, et al.
Publicado: (2005)

The CAF1-NOT complex of trypanosomes
por: Erben, Esteban, et al.
Publicado: (2014)

Fight the Cancer, Hit the CAF!
por: Papait, Andrea, et al.
Publicado: (2022)

Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor
por: Pang, Ning, et al.
Publicado: (2018)

Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs
por: Naruse, Mie, et al.
Publicado: (2021)

Mutation-Driven Signals of ARID1A and PI3K Pathways in Ovarian Carcinomas: Alteration Is An Opportunity
por: De, Pradip, et al.
Publicado: (2019)

Precision Medicine in Solid Tumors: How Far We Traveled So Far?
por: Dey, Nandini, et al.
Publicado: (2022)

The CMS CERN Analysis Facility (CAF)
por: Buchmuller, O, et al.
Publicado: (2010)

Integrin Regulation of CAF Differentiation and Function
por: DiPersio, C. Michael, et al.
Publicado: (2019)

The Cac1 subunit of histone chaperone CAF-1 organizes CAF-1-H3/H4 architecture and tetramerizes histones
por: Liu, Wallace H, et al.
Publicado: (2016)

A DNA binding winged helix domain in CAF-1 functions with PCNA to stabilize CAF-1 at replication forks
por: Zhang, Kuo, et al.
Publicado: (2016)

Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer
por: Wang, Ganggang, et al.
Publicado: (2023)

Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): An oncoprotein with many hands
por: De, Pradip, et al.
Publicado: (2014)

Author Correction: Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs
por: Naruse, Mie, et al.
Publicado: (2021)

Integrins, CAFs and Mechanical Forces in the Progression of Cancer
por: Jang, Imjoo, et al.
Publicado: (2019)

A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancers
por: Starks, David, et al.
Publicado: (2023)

Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers
por: De, Pradip, et al.
Publicado: (2016)

Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6
por: Lee, Young Eun, et al.
Publicado: (2023)

CAF-specific markers: role of the TGFβ pathway
por: Busch, Susann, et al.
Publicado: (2015)

PTCDA adsorption on CaF(2) thin films
por: Rahe, Philipp
Publicado: (2020)

Review: Challenges of In Vitro CAF Modelling in Liver Cancers
por: Herrero, Alba, et al.
Publicado: (2021)

Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
por: Gilardi, Laura, et al.
Publicado: (2022)

Epitaxial Growth of Crystalline CaF(2) on Silicene
por: Nazzari, Daniele, et al.
Publicado: (2022)

The importance of being CAFs (in cancer resistance to targeted therapies)
por: Rizzolio, Sabrina, et al.
Publicado: (2022)

CAF-immune cell crosstalk and its impact in immunotherapy
por: Maia, Ana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b1s6h316giute0o0btef758llt